The purpose of this trial is to describe the following, for each cohort, in real world conditions in France: - The characteristics and treatment sequence of patients treated with nivolumab - The effectiveness of nivolumab treatment - The safety profile of nivolumab - Treatment patterns (e.g. duration of treatment, subsequent treatments) of nivolumab - The patient-reported outcomes (PRO) in patients treated with nivolumab, at baseline and during follow up using the EuroQoL-5D-3L
Ask a Question?
Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others
Please enter valid email address.
Please enter all required fields.
